Home Blog Page 2

Climedo Blog

New blog posts and guest posts about decentralized clinical trials, digital health, EDC, ePRO, patient journeys, company news and more.

Sascha | Co-Founder & CEO

Kristina Weber | Product Lead , April 16, 2024

Think Global, Act Local: Best Practices for Holistic Real-World Evidence

Think Global, Act Local: Best Practices for Holistic Real-World Evidence
Arrow Right

Benjamin Sauer | VP Engineering, March 11, 2024

Trial Physician Survey: Status Quo in Clinical Research

Arrow Right
Trial Physician Survey: Status Quo in Clinical Research

Catherine | Associate Director Marketing, at Climedo, February 07, 2024

Using RWE to Leverage Diversity in Clinical Trials

Arrow Right
Using RWE to Leverage Diversity in Clinical Trials

Sascha | Co-Founder & CEO, at Climedo, January 19, 2024

Ultimate Guide: Successfully Identifying, Approaching and Engaging KOLs

Arrow Right
Ultimate Guide: Successfully Identifying, Approaching and Engaging KOLs

Dragan | Co-Founder & CTO, at Climedo, December 13, 2023

2023 in Review: Our Top Content and Climedo Connect Webinars

Arrow Right
2023 in Review: Our Top Content and Climedo Connect Webinars

Veronika | Co-Founder & COO, at Climedo, November 21, 2023

Engaging KOLs in the Post-Approval Phase – 3 Expert Tips

Arrow Right
Engaging KOLs in the Post-Approval Phase – 3 Expert Tips

Dr. David Schirmer I Head of Customer Success, October 18, 2023

Improving Clinical Trial Access with Patient-Centric Features

Arrow Right
Improving Clinical Trial Access with Patient-Centric Features
Load More

CLIMEDO IN THE NEWS

The impact of cineole treatment timing on common cold duration and symptoms: Non-randomized exploratory clinical trial Revolutionizing Clinical Trials: Physicians Embrace Digitalization for Scientific Advancement Survey reveals insights into physicians' perspectives on clinical trials and digitalization Climedo's survey about the patient perspective on clinical trials featured by Labiotech RAPS: Outlook for clinical trials: Digital and patient centric. Regulatory Focus. A guest article by Veronika Schweighart in Tagesspiegel Background (in German) Climedo's blog among the Top 80 European Healthcare Blogs People behind healthcare innovation: McKinsey Interview Climedo publishes new ePRO expert guide Climedo wins 2nd place for the Deloitte Fast 50 Award Climedo is among the "Health Tech Challengers" finalists Business Model Configurations in Digital Healthcare – a German Case Study about Digital Transformation Majority of diagnostic companies still implementing IVDR as deadline nears German healthtech startup Climedo picks up €5 million funding boost Outsourcing-Pharma: Survey: research industry keen on DCT benefits, slow to adopt Outsourcing-Pharma: Survey seeks to chart adoption of decentralized trials, future plans RAPS: Challenges and opportunities in medical device clinical trials in Europe CenterWatch: European Trials Lag Behind U.S. in Decentralization, Survey Finds Outsourcing-Pharma: Report reveals obstacles to implementing digital trial tech Healthcare Global: A guide to labelling compliance for medical devices Easy Medical Device: EU MDR Survey: What is the Industry’s opinion? RAPS: EU MDR Countdown: Readiness of medtech companies in Europe EPR: How small medical device manufacturers can achieve cost-effective compliant labelling MedTech Dive: EU MDR delay has not made new rules easier to stomach: exec poll RAPS: EU MDR survey: Time investment, costs, and personnel resources Easy Medical Device: What is the cost of an EU MDR project? Podcast: What is the true cost of the EU MDR? MedTech Insight: EU MDR Compliance Will Cost More Than 5% Of Revenues For Half Of Medtechs, Survey Says MedTechDive: EU MDR costing smaller medtechs 5% of their annual sales: survey Zollhof: Climedo’s digital symptom diary supported by Germany’s Federal Ministry of Health Helping MedTech companies comply with EU MDR: A case study Climedo Named Winner of EIT Health’s Headstart Program Medical Plastics News: How Covid-19 is impacting the medtech industry Survey results suggest medtech companies are not ready for EU MDR EIT Health: COVID-19 – Response from EIT Health Germany community